Medtronic shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 adjusted EPS guidance. Also, the company announced a $700 million strategic partnership with Cornerstone Robotics to expand global access to its Sentire Surgical System in select non-U.S. markets.